Iris Gonzalo-Sowle
Family · Saratoga Springs, NYNPI 1154783439
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,068, 2.7 times the $396 reported in 2021. Among family clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $106.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$362
- Otsuka Pharmaceutical Development & Commercialization, Inc.$335
- Sanofi-aventis U.S. LLC$259
- Novo Nordisk$250
- Medtronic$156
- Madrigal Pharmaceuticals$135
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,415100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $362 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $335 |
| Sanofi-aventis U.S. LLC | 3 | $259 |
| Novo Nordisk | 2 | $250 |
| Medtronic | 2 | $156 |
| Madrigal Pharmaceuticals | 1 | $135 |
| Boston Scientific | 1 | $132 |
| AstraZeneca | 1 | $131 |
| UCB, Inc. | 1 | $128 |
| Viatris Specialty LLC | 1 | $125 |
| Abiomed | 1 | $125 |
| Astellas Pharma US Inc | 1 | $125 |
| AbbVie | 1 | $124 |
| Ultragenyx Pharmaceutical Inc. | 1 | $120 |
| Neurocrine Biosciences, Inc. | 1 | $118 |
| Amgen | 1 | $114 |
| Axsome Therapeutics, Inc. | 1 | $107 |
| Teva Pharmaceuticals USA, Inc. | 1 | $105 |
| Biohaven Pharmaceuticals, Inc. | 1 | $104 |
| Alkermes, Inc. | 1 | $102 |
| Jazz Pharmaceuticals Inc. | 1 | $96 |
| Eisai Inc. | 1 | $83 |
| Neurelis, Inc. | 1 | $79 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$228
- REZDIFFRA$135
- WaveWriter Alpha Prime 16$132
- Rystiggo$128
- Saxenda$125
- Yupelri$125
- Wegovy$125
- Impella$125
- Veozah$125
- VRAYLAR$124
- CRYSVITA$120
- INGREZZA$118
- KRYSTEXXA$114
- Auvelity$107
- Austedo XR$105
- NURTEC ODT$104
How this compares
$3,415 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $3,972 |
| Celecoxib | 34 | $1,309 |
| Oxycodone Hcl | 76 | $493 |
| Ondansetron OdtOndansetron | 53 | $482 |
| Cephalexin | 52 | $239 |
| Tramadol Hcl | 51 | $175 |
| Omeprazole | 18 | $104 |
| Meloxicam | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other family in Saratoga Springs
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.